規制動向

FDA、EMA、TGA および世界の規制動向

#Lederle ×

2026年9月19日•1分で読めます

FDA NDA006920: Lederle's Triple Sulfas Oral Products Listed as Discontinued

The FDA’s NDA006920 for Lederle’s oral drug Triple Sulfas includes two discontinued formulations—a suspension and a tablet—both containing trisulfapyrimidines, sulfamerazine, and sulfamethazine.

2026年8月25日•1分で読めます

FDA Approves ANDA086746 for Amitriptyline Tablet – Lederle

FDA approved application ANDA086746 for an oral amitriptyline hydrochloride 25 mg tablet submitted by Lederle; the product is listed as discontinued.